Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2023 Nov 9;30(1):307. doi: 10.1038/s41591-023-02684-y

Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

Nicole L Welch 1,2,, Meilin Zhu 1,3, Catherine Hua 1,4, Juliane Weller 1,5, Marzieh Ezzaty Mirhashemi 1, Tien G Nguyen 1, Sreekar Mantena 1, Matthew R Bauer 1,6, Bennett M Shaw 1,4, Cheri M Ackerman 1,3, Sri Gowtham Thakku 1,7, Megan W Tse 1,3, Jared Kehe 1,3, Marie-Martine Uwera 1, Jacqueline S Eversley 4, Derek A Bielwaski 4, Graham McGrath 4, Joseph Braidt 4, Jeremy Johnson 1, Felecia Cerrato 1, Gage K Moreno 1, Lydia A Krasilnikova 1,8, Brittany A Petros 1,7,9,10, Gabrielle L Gionet 1, Ewa King 11, Richard C Huard 11, Samantha K Jalbert 10, Michael L Cleary 10, Nicholas A Fitzgerald 1, Stacey B Gabriel 1, Glen R Gallagher 12, Sandra C Smole 12, Lawrence C Madoff 12, Catherine M Brown 12, Matthew W Keller 13, Malania M Wilson 13, Marie K Kirby 13, John R Barnes 13, Daniel J Park 1, Katherine J Siddle 1,8, Christian T Happi 1,14,15, Deborah T Hung 1,16, Michael Springer 1,10, Bronwyn L MacInnis 1,17, Jacob E Lemieux 1,4, Eric Rosenberg 4,18, John A Branda 18, Paul C Blainey 1,3,19, Pardis C Sabeti 1,8,17,19,20,, Cameron Myhrvold 21,
PMCID: PMC10803257  PMID: 37946059

Correction to: Nature Medicine 10.1038/s41591-022-01734-1, published online 7 February 2022.

In the version of the article originally published, some of the oligonucleotide sequences in Supplementary Table 4, on the “21 viruses” and “RVP” tabs, were mislabeled. The Supplementary Tables file has now been corrected.

Contributor Information

Nicole L. Welch, Email: nicole_welch@g.harvard.edu

Pardis C. Sabeti, Email: pardis@broadinstitute.org

Cameron Myhrvold, Email: cmyhrvol@princeton.edu.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES